Cargando…

Proteomic Identification and Time-Course Monitoring of Secreted Proteins During Expansion of Human Mesenchymal Stem/Stromal in Stirred-Tank Bioreactor

The therapeutic potential of mesenchymal stem/stromal cells (MSC) is widely recognized for the treatment of several diseases, including acute graft-vs.-host disease (GVHD), hematological malignancies, cardiovascular, bone, and cartilage diseases. More recently, this therapeutic efficacy has been att...

Descripción completa

Detalles Bibliográficos
Autores principales: Mizukami, Amanda, Thomé, Carolina Hassibe, Ferreira, Germano Aguiar, Lanfredi, Guilherme Pauperio, Covas, Dimas Tadeu, Pitteri, Sharon J., Swiech, Kamilla, Faça, Vitor Marcel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6607109/
https://www.ncbi.nlm.nih.gov/pubmed/31297369
http://dx.doi.org/10.3389/fbioe.2019.00154
_version_ 1783432028095512576
author Mizukami, Amanda
Thomé, Carolina Hassibe
Ferreira, Germano Aguiar
Lanfredi, Guilherme Pauperio
Covas, Dimas Tadeu
Pitteri, Sharon J.
Swiech, Kamilla
Faça, Vitor Marcel
author_facet Mizukami, Amanda
Thomé, Carolina Hassibe
Ferreira, Germano Aguiar
Lanfredi, Guilherme Pauperio
Covas, Dimas Tadeu
Pitteri, Sharon J.
Swiech, Kamilla
Faça, Vitor Marcel
author_sort Mizukami, Amanda
collection PubMed
description The therapeutic potential of mesenchymal stem/stromal cells (MSC) is widely recognized for the treatment of several diseases, including acute graft-vs.-host disease (GVHD), hematological malignancies, cardiovascular, bone, and cartilage diseases. More recently, this therapeutic efficacy has been attributed to the bioactive molecules that these cells secrete (secretome), now being referred as medicinal signaling cells. This fact raises the opportunity of therapeutically using MSC-derived soluble factors rather than cells themselves, enabling their translation into the clinic. Indeed, many clinical trials are now studying the effects of MSC-secretome in the context of cell-free therapy. MSC secretome profile varies between donors, source, and culture conditions, making their therapeutic use very challenging. Therefore, identifying these soluble proteins and evaluating their production in a reproducible and scalable manner is even more relevant. In this work, we analyzed the global profile of proteins secreted by umbilical cord matrix (UCM) derived-MSC in static conditions by using mass spectrometry, enabling the identification of thousands of proteins. Afterwards, relevant proteins were chosen and monitored in the supernatant of a fully-controllable, closed and scalable system (bioreactor) by using multiple reaction monitoring (MRM) mass spectrometric technique in a time-dependent manner. The results showed that the majority of interesting proteins were enriched through time in culture, with the last day of culture being the ideal time for supernatant collection. The use of this regenerative “soup,” which is frequently discarded, could represent a step toward a safe, robust and reproducible cell-free product to be used in the medical therapeutic field. The future use of chemically defined culture-media will certainly facilitate secretome production according to Good Manufacturing Practice (GMP) standards.
format Online
Article
Text
id pubmed-6607109
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-66071092019-07-11 Proteomic Identification and Time-Course Monitoring of Secreted Proteins During Expansion of Human Mesenchymal Stem/Stromal in Stirred-Tank Bioreactor Mizukami, Amanda Thomé, Carolina Hassibe Ferreira, Germano Aguiar Lanfredi, Guilherme Pauperio Covas, Dimas Tadeu Pitteri, Sharon J. Swiech, Kamilla Faça, Vitor Marcel Front Bioeng Biotechnol Bioengineering and Biotechnology The therapeutic potential of mesenchymal stem/stromal cells (MSC) is widely recognized for the treatment of several diseases, including acute graft-vs.-host disease (GVHD), hematological malignancies, cardiovascular, bone, and cartilage diseases. More recently, this therapeutic efficacy has been attributed to the bioactive molecules that these cells secrete (secretome), now being referred as medicinal signaling cells. This fact raises the opportunity of therapeutically using MSC-derived soluble factors rather than cells themselves, enabling their translation into the clinic. Indeed, many clinical trials are now studying the effects of MSC-secretome in the context of cell-free therapy. MSC secretome profile varies between donors, source, and culture conditions, making their therapeutic use very challenging. Therefore, identifying these soluble proteins and evaluating their production in a reproducible and scalable manner is even more relevant. In this work, we analyzed the global profile of proteins secreted by umbilical cord matrix (UCM) derived-MSC in static conditions by using mass spectrometry, enabling the identification of thousands of proteins. Afterwards, relevant proteins were chosen and monitored in the supernatant of a fully-controllable, closed and scalable system (bioreactor) by using multiple reaction monitoring (MRM) mass spectrometric technique in a time-dependent manner. The results showed that the majority of interesting proteins were enriched through time in culture, with the last day of culture being the ideal time for supernatant collection. The use of this regenerative “soup,” which is frequently discarded, could represent a step toward a safe, robust and reproducible cell-free product to be used in the medical therapeutic field. The future use of chemically defined culture-media will certainly facilitate secretome production according to Good Manufacturing Practice (GMP) standards. Frontiers Media S.A. 2019-06-26 /pmc/articles/PMC6607109/ /pubmed/31297369 http://dx.doi.org/10.3389/fbioe.2019.00154 Text en Copyright © 2019 Mizukami, Thomé, Ferreira, Lanfredi, Covas, Pitteri, Swiech and Faça. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Bioengineering and Biotechnology
Mizukami, Amanda
Thomé, Carolina Hassibe
Ferreira, Germano Aguiar
Lanfredi, Guilherme Pauperio
Covas, Dimas Tadeu
Pitteri, Sharon J.
Swiech, Kamilla
Faça, Vitor Marcel
Proteomic Identification and Time-Course Monitoring of Secreted Proteins During Expansion of Human Mesenchymal Stem/Stromal in Stirred-Tank Bioreactor
title Proteomic Identification and Time-Course Monitoring of Secreted Proteins During Expansion of Human Mesenchymal Stem/Stromal in Stirred-Tank Bioreactor
title_full Proteomic Identification and Time-Course Monitoring of Secreted Proteins During Expansion of Human Mesenchymal Stem/Stromal in Stirred-Tank Bioreactor
title_fullStr Proteomic Identification and Time-Course Monitoring of Secreted Proteins During Expansion of Human Mesenchymal Stem/Stromal in Stirred-Tank Bioreactor
title_full_unstemmed Proteomic Identification and Time-Course Monitoring of Secreted Proteins During Expansion of Human Mesenchymal Stem/Stromal in Stirred-Tank Bioreactor
title_short Proteomic Identification and Time-Course Monitoring of Secreted Proteins During Expansion of Human Mesenchymal Stem/Stromal in Stirred-Tank Bioreactor
title_sort proteomic identification and time-course monitoring of secreted proteins during expansion of human mesenchymal stem/stromal in stirred-tank bioreactor
topic Bioengineering and Biotechnology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6607109/
https://www.ncbi.nlm.nih.gov/pubmed/31297369
http://dx.doi.org/10.3389/fbioe.2019.00154
work_keys_str_mv AT mizukamiamanda proteomicidentificationandtimecoursemonitoringofsecretedproteinsduringexpansionofhumanmesenchymalstemstromalinstirredtankbioreactor
AT thomecarolinahassibe proteomicidentificationandtimecoursemonitoringofsecretedproteinsduringexpansionofhumanmesenchymalstemstromalinstirredtankbioreactor
AT ferreiragermanoaguiar proteomicidentificationandtimecoursemonitoringofsecretedproteinsduringexpansionofhumanmesenchymalstemstromalinstirredtankbioreactor
AT lanfrediguilhermepauperio proteomicidentificationandtimecoursemonitoringofsecretedproteinsduringexpansionofhumanmesenchymalstemstromalinstirredtankbioreactor
AT covasdimastadeu proteomicidentificationandtimecoursemonitoringofsecretedproteinsduringexpansionofhumanmesenchymalstemstromalinstirredtankbioreactor
AT pitterisharonj proteomicidentificationandtimecoursemonitoringofsecretedproteinsduringexpansionofhumanmesenchymalstemstromalinstirredtankbioreactor
AT swiechkamilla proteomicidentificationandtimecoursemonitoringofsecretedproteinsduringexpansionofhumanmesenchymalstemstromalinstirredtankbioreactor
AT facavitormarcel proteomicidentificationandtimecoursemonitoringofsecretedproteinsduringexpansionofhumanmesenchymalstemstromalinstirredtankbioreactor